The short answer
Taking calcium supplements at the same time as oral levothyroxine can reduce its absorption and worsen thyroid-hormone control. The direct studies involved specific calcium salts, so the findings do not establish the same effect for every calcium preparation.
What this answer covers
Evidence concerns oral levothyroxine tablets with calcium carbonate, citrate or acetate; it does not apply to injected levothyroxine.
- Supplement or preparation
- Calcium
- Medication ingredient
- levothyroxine
Evidence and practical considerations
Absorption & effectiveness
Two direct human studies plus current labeling consistently establish reduced oral levothyroxine absorption with simultaneous calcium supplementation. The evidence is clinically meaningful but based on small studies and specific salts.
- Exact scope
- calcium supplements with levothyroxine
- Medication form and route
- oral levothyroxine tablets
- Timing or duration
- Interaction can occur with simultaneous dosing; sustained daily coadministration over three months produced biochemical loss of control.
What remains uncertain
- Evidence is oral and does not apply to injectable levothyroxine.
- The magnitude is established for calcium carbonate, citrate, and acetate; no automatic conclusion is made for every calcium preparation.
- Marketed-product evidence uses levothyroxine sodium and requires the documented active-moiety bridge.
Factors that may matter: calcium salt and elemental dose; simultaneous administration; oral formulation; gastrointestinal malabsorption; narrow therapeutic index.
Read the supporting source summaries
Source 1: peer-reviewed prospective human cohort with in-vitro binding study
pubmed.ncbi.nlm.nih.gov · Source check Jul 24, 2026
Population: Twenty adults with hypothyroidism receiving stable long-term levothyroxine.
Free and total T4 fell and TSH rose during calcium coadministration; values improved after calcium withdrawal. Acidic-pH adsorption supported reduced bioavailability.
Small non-placebo cohort; one calcium salt and tablet context; no clinical-outcome endpoint.
Source 2: peer-reviewed human pharmacokinetic crossover study
pmc.ncbi.nlm.nih.gov · Source check Jul 24, 2026
Population: Eight healthy euthyroid adults.
All three calcium formulations reduced levothyroxine absorption by approximately 20% to 25% when coadministered.
Very small healthy-volunteer, supratherapeutic single-dose study; not designed for long-term TSH or clinical outcomes.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Research summary published |
Article revision: 34f1099a5088a8f4
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.